-- VectorCertain introduces MRM-CFS, ultra-compact AI models for improved safety in edge cases. -- Existing AI systems fail on rare events; MRM-CFS offers precise detection and fusion solutions. -- ...
On February 10 morning each year, in select villages and urban settlements across India, frontline health workers walk door ...
As AI systems increasingly control life-and-death decisions--from autonomous vehicles to medical diagnostics to financial markets--a ...
Kwara State surpasses WHO benchmarks with over 90% coverage in treating Neglected Tropical Diseases, successfully ...
The High Court has issued an unless order requiring Samyung ENC Co Limited to comply with disclosure obligations by 13 ...
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...
Clinical Trials Arena on MSN
FDA puts REGENXBIO gene therapy trials on hold after brain tumour
A five-year-old patient dosed with RGX-111 has developed a brain tumour four years after being dosed with the gene therapy.
February may feel like a quiet month, but that’s not always true in wilderness areas or for animals crossing roads. In many ...
QKS Group announced today that it has named VIPRE Security Group as a 2025 technology leader in the SPARK Matrixtm: Enterprise Email Security, 2025.
In this week's newsletter, Rikard Jozwiak focuses on how to prevent former Russian soldiers from entering the EU.
We came across a bullish thesis on Lam Research Corporation on MTC’s Substack. In this article, we will summarize the bulls’ thesis on LRCX. Lam Research Corporation’s share was trading at $213.31 as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results